ArticlePDF Available

Pre-Pregnancy BMI, Gestational Weight Gain, and the Risk of Hypertensive Disorders of Pregnancy: A Cohort Study in Wuhan, China

PLOS
PLOS ONE
Authors:

Abstract and Figures

Hypertensive disorders of pregnancy (HDP) are major causes of maternal death worldwide and the risk factors are not fully understood. Few studies have investigated the risk factors for HDP among Chinese women. A cohort study involving 84,656 women was conducted to investigate pre-pregnancy BMI, total gestational weight gain (GWG), and GWG during early pregnancy as risk factors for HDP among Chinese women. The study was conducted between 2011-2013 in Wuhan, China, utilizing data from the Maternal and Children Healthcare Information Tracking System of Wuhan. A total of 84,656 women with a live singleton pregnancy were included. Multiple unconditional logistic regression was conducted to evaluate associations between putative risk factors and HDP. Women who were overweight or obese before pregnancy had an elevated risk of developing HDP (overweight: OR = 2.66, 95% CI = 2.32-3.05; obese: OR = 5.53, 95% CI = 4.28-7.13) compared to their normal weight counterparts. Women with total GWG above the Institute of Medicine (IOM) recommendation had an adjusted OR of 1.72 (95% CI = 1.54-1.93) for HDP compared to women who had GWG within the IOM recommendation. Women with gestational BMI gain >10 kg/m2 during pregnancy had an adjusted OR of 3.35 (95% CI = 2.89-3.89) for HDP, compared to women with a gestational BMI gain <5 kg/m2. The increased risk of HDP was also observed among women with higher early pregnancy (up to 18 weeks of pregnancy) GWG (>600g/wk: adjusted OR = 1.48, 95% CI = 1.19-1.84). The results from this study show that maternal pre-pregnancy BMI, early GWG, and total GWG are positively associated with the risk of HDP. Weight control efforts before and during pregnancy may help to reduce the risk of HDP.
Content may be subject to copyright.
RESEARCH ARTICLE
Pre-Pregnancy BMI, Gestational Weight Gain,
and the Risk of Hypertensive Disorders of
Pregnancy: A Cohort Study in Wuhan, China
Aifen Zhou
1
, Chao Xiong
1,4
, Ronghua Hu
1
, Yiming Zhang
1
, Bryan A. Bassig
2
,
Elizabeth Triche
3
, Shaoping Yang
1
, Lin Qiu
1
, Yaqi Zhang
1
, Cong Yao
1
, Shunqing Xu
4
,
Youjie Wang
4
, Wei Xia
4
, Zhengmin Qian
5
, Tongzhang Zheng
2
*, Bin Zhang
1
*
1 Wuhan Women and Children Health Care Center, Wuhan, Hubei, Peoples Republic of China,
2 Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, United
States of America, 3 Department of Epidemiology, Brown University School of Public Health, Providence, RI,
United States of America, 4 Key Laboratory of Environment and Health, School of Public Health, Tongji
Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, Peoples Republic of
China, 5 Department of Epidemiology, College for Public Health and Social Justice, Saint Louis University,
MO, United States of America
These authors contributed equally to this work.
* mchwhzb@163.com (BZ); tongzhang.zheng@yale.edu (TZ)
Abstract
Background
Hypertensive disorders of pregnancy (HDP) are major causes of maternal death worldwide
and the risk factors are not fully understood. Few studies have investigated the risk factors
for HDP among Chinese women. A cohort study involving 84,656 women was conducted to
investigate pre-pregnancy BMI, total gestational weight gain (GWG ), and GWG during early
pregnancy as risk factors for HDP among Chinese women.
Methods
The study was conducted between 20112013 in Wuhan, China, utilizing data from the
Maternal and Children Healthcare Information Tracking System of Wuhan. A total of 84,656
women with a live singleton pregnancy were included. Multiple unconditional logistic regres-
sion was conducted to evaluate associations between putative risk factors and HDP.
Results
Women who were overweight or obese before pregnancy had an elevated risk of develop-
ing HDP (overweight: OR = 2.66, 95% CI = 2.323.05; obese: OR = 5. 53, 95% CI = 4.28
7.13) compared to their normal weight counterparts. Women with total GWG above the Insti-
tute of Medicine (IOM) recommendation had an adjusted OR of 1.72 (95% CI = 1.541.93)
for HDP compared to women who had GWG within the IOM recommendation. Women with
gestational BMI gain >10 kg/m
2
during preg nancy had an adjusted OR of 3.35 (95% CI =
2.893.89) for HDP, compared to women with a gestational BMI gain <5 kg/m
2
. The
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 1/10
OPEN ACCESS
Citation: Zhou A, Xiong C, Hu R, Zhang Y, Bassig
BA, Triche E, et al. (2015) Pre-Pregnancy BMI,
Gestational Weight Gain, and the Risk of
Hypertensive Disorders of Pregnancy: A Cohort
Study in Wuhan, China. PLoS ONE 10(8): e0136291.
doi:10.1371/journal.pone.0136291
Editor: Cheryl S. Rosenfeld, University of Missouri,
UNITED STATES
Received: March 17, 2015
Accepted: August 2, 2015
Published: August 25, 2015
Copyright: © 2015 Zhou et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Data are available from the Wuhan Women and
Children Health Care Center for researchers who
meet the criteria for access to confidential data.
Funding: This work was supported by the Fogarty
training grants D43TW 008323 and D43TW 007864-
01 from the US National Institutes of Health (http://
www.nih.gov/), and Dr. Tongzhang Zheng received
the funding. The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
increased risk of HDP was also observed among women with higher early pregnancy (up to
18 weeks of pregnancy) GWG (>600g/wk: adjusted OR = 1.48, 95% CI = 1.191.84).
Conclusion
The results from this study show that maternal pre-pregnancy BMI, early GWG, and total
GWG are positively associated with the risk of HDP. Weight control efforts before and dur-
ing pregnancy may help to reduce the risk of HDP.
Introduction
Hypertensive disorders of pregnancy (HDP), consisting of gestational hypertension (GH) and
preeclampsia (PE), are major causes of maternal and perinatal morbidity and mortality [1]. It has
been reported that HDP complicates 510% of all pregnancies worldwide and causes up to 70,000
maternal deaths each year [2]. In addition to maternal complications, HDP is also associated with
fetal intrauterine growth restriction and preterm birth [3]. However, effective treatments for HDP
are still limited, and currently the etiology of HDP is not completely understood [4].
Previous studies in developed countries have linked pre-pregnancy obesity to the develop-
ment of HDP suggesting that the risk factors for this condition may not be limited to exposures
during the gestational period [5, 6]. On the other hand, there is increasing concern about
whether gestational weight gain (GWG) may influence the development of HDP and to what
extent control of GWG can reduce the risk of HDP. Several studies have indicated that HDP is
more likely to develop in women with greater GWG [79]. However, the majority of previous
studies have only evaluated total GWG during pregnancy in relation to risk of HDP; given that
women with HDP are likely to experience edema during pregnancy [10], which may result in
greater GWG, it is hard to distinguish the weight gain caused by edema from the weight gain
independent of this condition [11]. Therefore, whether GWG is causally related to the develop-
ment of HDP is still unclear. To our knowledge, there has been only one study, which was con-
ducted in the United Kingdom, that addressed this issue by assessing weight gain during early
pregnancy that was likely not the result of edema. Some positive associations between greater
GWG in early pregnancy and increased risk of developing gestational hypertension and pre-
eclampsia were observed in that study [11].
Although the impact of HDP is thought to be much more severe in developing countries than
in developed countries [12], there are limited epidemiological studies that have evaluated risk
factors for HDP among women in developing countries, including in China. As Asian women
generally have a lower BMI prior to pregnancy compared to women in Western countries [13],
the relationship between pre-pregnancy BMI, GWG, and risk of HDP among Asian women may
differ, although these hypotheses have not been extensively studied. Therefore, we conducted a
cohort study to evaluate the association of pre-pregnancy BMI, total GWG, and early pregnancy
GWG with risk of HDP among a relatively large population of women from Wuhan, China.
Methods
Study Population
This is a cohort study conducted in Wuhan, China, utilizing data from the Maternal and Chil-
dren Healthcare Information Tracking System of Wuhan. The tracking system includes infor-
mation pertaining to demographic characteristics, medical history, prenatal examinations,
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 2/10
Competing Interests: The authors have declared
that no competing interests exist.
deliveries, and postnatal visits for mothers and infants from all of the 93 hospitals and 121
community health centers in Wuhan. Enrolled women in our study included those without a
history of chronic hypertension or cardiovascular disease prior to pregnancy, who lived in the
urban area of Wuhan during pregnancy, and who delivered a live singleton newborn with no
birth defects and gestational age no less than 28 weeks between June 1, 2011 and June 10, 2013.
A total of 97,582 women were enrolled initially. We then excluded those with any missing
values for height, pre-pregnancy weight, or GWG. To eliminate extreme outliers, data analysis
was also limited to women whose height, weight, and GWG were within 5 standard deviations
of the mean. A total of 84,656 women met these criteria and were included in the analysis;
63,603 of them had a record of at least one weight measurement during early pregnancy (818
weeks). Informed consent was not obtained because data from this study were abstracted from
the healthcare information system without individual identification, and the research protocol
was approved by the Institutional Review Board of Wuhan Women and Children Health Care
Center, in accordance to the principles of the Declaration of Helsinki. All patient records were
anonymized and de-identified prior to analysis.
Exposure Information
Weight measurements during pregnancy were taken routinely as part of antenatal care at the
clinic. Pre-pregnancy weight and height were self-reported at the first antenatal care visit (usu-
ally in the first trimester). Pre-pregnancy BMI was calculated as weight (in kg)/height (in
meters) squared and categorized into four groups based on recommendations by the Working
Group On Obesity in China of the Chinese Ministry of Health: underweight (<18.5 kg/m
2
),
normal weight (18.523.9 kg/m
2
), overweight (2427.9 kg/m
2
), and obese (28 kg/m
2
)[14].
Total GWG was calculated by subtracting pre-pregnancy weight from the weight on deliv-
ery day. GWG was categorized according to the recommendations of the Institute of Medicine
(IOM) (2009) [15]. GWG within the IOM recommendations was defined as 12.518 kg, 11.5
16 kg, 711.5 kg, and 59 kg respectively for underweight, normal weight, overweight, and
obese women.
Weight measurements between 818 weeks gestation were used to evaluate GWG during
early pregnancy. GWG during early pregnancy was evaluated as the average GWG per week up
to 18 weeks of pregnancy, and classified as class I (<200 g/week), class II (200400 g/week),
class III (400600 g/week), and class IV (> 600 g/week) [11].
Gestational BMI gain was categorized as minimal (<5 kg/m
2
), moderate (510 kg/m
2
), and
excessive (> 10 kg/m
2
) based on evidence from a previous study [7]. Each one point increase
in BMI is roughly equivalent to 2.5 kg in weight gain, using the Chinese nat ional average for
female height at reproductive age (158 cm, 54 kg) [14].
Outcome Assessment
Gestational hypertension and preeclampsia were defined according to the International Society
for the Study of Hypertension [16]. Gestational hypertension was defined as having a maternal
systolic blood pressure (SBP) > 140 mm Hg and/or diastolic blood pressure (DBP) > 90
mmHg, measured on 2 occasions separated by at least 6 hours beginning after 20 weeks gesta-
tion. Preeclampsia was defined using the same criteria in conjunction with proteinuria > 300mg
on a 24-hour urine collection or proteinuria of at least 1+ on dipstick testing [16].
Statistical Analysis
Unconditional logistic regression was conducted to calculate odds ratios (ORs) and 95% confi-
dence intervals (CIs) evaluating the association of each factor (pre-pregnancy BMI, total
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 3/10
pregnancy GWG, GWG in early pregnancy, and gestational BMI gain) and risk of HDP overall,
as well as risk of gestational hypertension and preeclampsia separately. Models were adjusted
for other previously identified risk factors for HDP including maternal age at delivery, educa-
tion level, parity, offspring sex, and gestational week. Separate models were run to evaluate the
associations with HDP for total GWG, GWG during early pregnancy, and gestational BMI
gain, and all of these models were also adjusted for pre-pregnancy BMI. Additionally, models
evaluating the risk of HDP for pre-pregnancy BMI and gestational BMI gain were mutually
adjusted. Analyses were further stratified by maternal pre-pregnancy BMI categories, and the
interactions between GWG and pre-pregnancy BMI were assessed using a Wald test by includ-
ing the relevant cross-product terms in the regression models. Linear trends were tested using
the Wald test. Statistical analyses were conducted using SAS, version 9.3, (SAS Institute, Inc.,
Cary, North Carolina) and P < 0.05 was considered statistically significant.
Results
Table 1 shows selected characteristics of women in the cohort. 1,973 out of 84,656 (2.33%)
women were diagnosed with HDP (including 1,244 cases of GH and 729 cases of PE). Women
aged over 30 years, nulliparous women, and women who were overweight/ obese before preg-
nancy were more likely to develop HDP. The mean total GWG among women who developed
HDP was 19.52±8.21 kg, higher than that of normotensive women (17.44±7.00 kg). The aver-
age GWG up to 18 weeks was also higher among women with HDP (0.219±0.209kg/wk) com-
pared with normotensive women (0.201±0.188kg/wk).
Table 2 presents the associations of pre-pregnancy BMI, gestational BMI gain, total GWG,
and GWG during early pregnancy in relation to risk of HDP . In the model adjusted for con-
founders, pre-pregnancy BMI, gestational BMI gain, and GWG were all positively associated
with the risk of HDP. Women who were obese prior to pregnancy were about 5 times more
likely to develop HDP, compared with women who had a normal pre-pregnancy BMI (adjusted
OR = 5.53, 95% CI = 4.287.13). A significantly increased risk of HDP was also observed for
women with a BMI gain greater than 10 kg/m
2
during pregnancy (adjusted OR = 3.35, 95%
CI = 2.893.89). Furthermore, women with GWG above the IOM recommendation had an
adjusted OR of 1.72 (95% CI = 1.541.93) for developing HDP compared with women who
had GWG within the recommendation.
An increasing risk of HDP was also observed as GWG increased during early pregnancy (p
trend < 0.01). Compared with women who gained less than 200 grams per week before 18
weeks of pregnancy, the risk of developing HDP was significantly higher among women who
gained greater than 400 grams per week (OR = 1.26, 95% CI = 1.071.50). Notably, women
who gained greater than 600 grams per week during early pregnancy had the highest risk of
HDP with an adjusted OR of 1.48 (CI = 1.191.84).
Results for gestational BMI gain, total GWG, and GWG during early pregnancy stratified by
pre-pregnancy BMI are presented in Table 3. Women with higher BMI gain and GWG during
the whole pregnancy had a significantly elevated risk of developing HDP across all pre-preg-
nancy BMI categories. However, the odds ratio for higher BMI gain and GWG decreased as the
pre-pregnancy BMI increased. In particular, women who were underweight before pregnancy
and who had higher gestational BMI gain (10 kg/m
2
) had the highest risk of developing HDP
(adjusted OR = 3.46, CI = 2.075.78), whereas the corresponding ORs were still elevated but
not as strong in women with higher BMI gain who were overweight or obese before pregnancy
(P for heterogeneity < 0.01).
A different trend was apparent fo r the association of early pregnancy GWG and HDP
stratified by pre-pregna ncy BMI ( Table 3). No significantly increased risk of HDP was
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 4/10
observed among women who were underweight before pr egnancy and who had the highest
GWG during early pregnancy (highest level vs lowest level : adjusted OR = 1.34, 95%
CI = 0.712.55). Among women with a pre-pregnancy B MI ca tegory classified a s norma l or
overweight/obese, the highest level of GW G (600g/week) during early pregnancy signifi-
cantly elevated the risk of developing HDP, compared to the lowest level of early GWG
(among normal weight women: adjusted OR = 1.42, 95% CI = 1.091.85; among overweight/
obese women: adjusted OR = 1.79, 95% CI = 1.092.94). There was, however, no significant
heterogeneity between pre-pregnancy BMI categories for the association of GWG during
early pregnancy and HDP risk (P for heterogeneity = 0.71).
Additionally, we assessed the associations of pre-pregnancy BMI, gestational BMI gain,
total GWG, and GWG during early pregnancy with risk of gestational hypertension and pre-
eclampsia separately. These two outcomes were positively associated with all of the evaluated
exposures and the magnitudes of the associat ions were similar (S1 and S2 Tables).
Table 1. Distribution of selected characteristics of the cohort stratified by HDP status.
Maternal characteristic Normotensive
(n = 82,683)
HDP(n = 1,973)
n/mean %/SD n/mean %/SD
Age at delivery
<25 15664 18.94 237 12.01
2529 42705 51.65 926 46.93
3034 19009 22.99 556 28.18
35 5305 6.42 254 12.87
Education Level
Less than high school 9515 11.51 222 11.25
High school 37264 45.07 856 43.39
College 31801 38.46 795 40.29
Advanced Degree 4103 4.96 100 5.07
Parity
Nulliparous 68775 83.18 1687 85.50
Multiparous 13908 16.82 286 14.50
Offspring Sex
Male 44097 53.33 1024 51.90
Female 38586 46.67 949 48.10
Gestational week
<37 3030 3.66 266 13.48
3741 78612 95.08 1691 85.71
42 1041 1.26 16 0.81
Pre-pregnancy BMI(kg/m
2
)
Under weight (<18.5) 14146 17.11 208 10.54
Normal (18.523.9) 63271 76.52 1419 71.92
Overweight (2427.9) 4648 5.62 273 13.84
Obese(28) 618 0.75 73 3.70
Total GWG(Kg) 17.44 7.00 19.52 8.21
Average GWG up to 18 weeks (Kg/wk)* 0.201 0.188 0.219 0.209
*Includes 63,603 subjects with at least one weight measurement during the early pregnancy period
doi:10.1371/journal.pone.0136291.t001
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 5/10
Discussion
During the past decades, HDP remains a leading cause of maternal death worldwide [12]. Pre-
vious studies conducted in developed countries have indicated that obesity and excessive
weight gain during pregnancy pose a significant risk for developing HDP [11, 17, 18]. However,
there have been limited epidemiological studies about risk factors for HDP among Chinese
women.
In this large cohort study conducted among Chinese women, we found that maternal over-
weight /obesity before pregnancy was independently associated with an increased risk of HDP,
compared with women with lower pre-pregnan cy BMI, which is consistent with previous stud-
ies [ 7, 19, 20]. It has been postulated that maternalfetal immune maladaptation is involved in
the pathogenesis of preeclampsia [1, 21, 22]. Adipose tissue is known to be associated with met-
abolic syndrome including adiposity and hyperlipidemia, which can cause inflammatory
changes and then lead to an increase in oxidative stress. This may result in endothelial dysfunc-
tion, maternal organ hypo perfusion, and eventually clinical diseases such as HDP [23, 24].
Previous studies have also suggested that adipose tissue may stimulate angiogenesis, which has
been recently implicated to be involved in the development of hypertension [25].
Although several previous studies have reported a positive association between excessive
GWG and the risk of HDP, the association has not been confirmed due to the generally limited
number of studies and the potential limitations of previous study designs [26]. The majority of
studies only evaluated the absolute GWG over the entire pregnancy with the risk of HDP and
did not distinguish the weight gain driven by edema and the weight gain caused by adiposity.
Table 2. Associations of pre-pregnancy BMI, gestational BMI gain, total GWG, and GWG during early pregnancy with risk of HDP
a
.
Exposure Variables Normotensive(n) HDP(n) Crude OR(95% CI) Adjusted OR(95% CI)*
Pre-pregnancy BMI(kg/m
2
)
b
Under weight (<18.5) 14146 208 0.66(0.570.76) 0.64(0.550.74)
Normal (18.523.9) 63271 1419 1.00 (ref) 1.00 (ref)
Overweight (2427.9) 4648 273 2.62(2.292.99) 2.66(2.323.05)
Obese(28) 618 73 5.27(4.116.75) 5.53(4.287.13)
Gestational BMI gain (kg/m
2
)
b
<5 20345 384 1.00 (ref) 1.00 (ref)
510 53423 1195 1.19(1.061.33) 1.46(1.291.64)
10 8915 394 2.34(2.032.70) 3.35(2.893.89)
Total GWG By IOM Recommendation
b
Below 14012 220 0.88(0.751.04) 0.88(0.751.04)
Within 24927 443 1.00 (ref) 1.00 (ref)
Above 43744 1310 1.69(1.511.88) 1.72(1.541.93)
Average GWG up to 18weeks(g/wk)
c
<200 37851 803 1.00 (ref) 1.00 (ref)
200399 15181 342 1.06(0.931.21) 1.07(0.941.22)
400599 6199 170 1.29(1.091.53) 1.26(1.071.50)
600 2963 94 1.50(1.201.86) 1.48(1.191.84)
P for trend <0.01
a
. Gestational BMI gain, total GWG, and GWG during early pregnancy were evaluated in separate models.
b
. Adjusted for age at delivery, education level, parity, offspring sex, and gestational week. Additionally, pre-pregnancy BMI and gestational BMI gain were
mutually adjusted. Total GWG also adjusted for pre-pregnancy BMI. (n = 84,656)
c
. Adjusted for age at delivery, education level, parity, offspring sex, and pre-pregnancy BMI. (n = 63,603)
doi:10.1371/journal.pone.0136291.t002
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 6/10
As edema is one of the hallmarks of preeclampsia, the etiologic association of GWG and pre-
eclampsia is uncertain in those studies [7, 27], as weight gain during pregnancy may be the
result of edema caused by preeclampsia. To our knowledge, there has been only one study to
date, which was conducted in the United Kingdom [11], that attempted to account for the
weight caused by edema by assessing weight gain during early pregnancy. That study found a
positive association between GWG in early pregnancy and risk of HDP. However, there have
been no such studies among Asian women. In the present study, we found that excessive GWG
during the whole pregnancy was significantly associated with an increased risk of HDP after
adjusting for gestational weeks, which is consistent with previous studies [7, 11]. As BMI is
considered by some to be a better measure of adiposity than weight alone [7], we also classified
antenatal weight gain according to the net change in BMI, and similarly, excessive BMI gain
during pregnancy was shown to be related to an elevated risk of HDP. We additionally evalu-
ated the association of early pregnancy GWG and risk of HDP, and the data indicated that
weight gain before 18 weeks gestation was also positively associated with the risk of HDP. This
association is unlikely to be explained by edema because edema is unlikely to happen at this
stage of pregnancy, which demonstrates that GWG may precede the development of HDP.
Table 3. Associations of gestational BMI gain, total GWG, and GWG during early pregnancy with risk of HDP stratified by pre-pregnancy BMI
a
.
Exposure Variables under-weight (<18.5 kg/m
2
) Normal (18.523.9 kg/m
2
) Overweight/Obese(24 kg/
m
2
)
P for
heterogeneity
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Gestational BMI gain (kg/
m
2
)
b
<5 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) <0.01
510 1.19(0.75
1.87)
1.35(0.852.14) 1.35(1.17
1.56)
1.45(1.251.67) 1.41(1.11
1.79)
1.47(1.161.87)
10 2.80(1.69
4.62)
3.46(2.075.78) 2.94(2.49
3.48)
3.40(2.874.04) 2.12(1.3
3.45)
2.27(1.393.73)
Total GWG By IOM
Recommendation
b
Below 1.31(0.77
2.23)
1.20(0.702.05) 0.82(0.68
0.99)
0.83(0.691.00) 0.77(0.46
1.28)
0.86(0.521.45) 0.35
Within 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Above 2.34(1.69
3.23)
2.72(1.953.79) 1.46(1.29
1.66)
1.65(1.451.87) 1.45(1.08
1.95)
1.57(1.162.11)
Average GWG up to
18weeks(g/wk)
c
<200 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 0.71
200399 0.95(0.63
1.44)
0.94(0.621.43) 1.06(0.92
1.24)
1.04(0.901.21) 1.27(0.93
1.73)
1.28(0.941.74)
400599 1.41(0.88
2.28)
1.40(0.872.25) 1.25(1.02
1.53)
1.21(0.991.49) 1.35(0.92
1.98)
1.34(0.911.97)
600 1.38(0.73
2.62)
1.34(0.712.55) 1.48(1.14
1.93)
1.42(1.091.85) 1.75(1.07
2.86)
1.79(1.092.94)
P for trend 0.19 <0.01 <0.01
a
. Gestational BMI gain, total GWG, and GWG during early pregnancy were evaluated in separate models.
b
. Adjusted for age at delivery, education level, parity, offspring sex, and gestational week. (n = 84,656)
c
. Adjusted for age at delivery, education level, parity, and offspring sex. (n = 63,603)
doi:10.1371/journal.pone.0136291.t003
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 7/10
It was found in some studies that an increased risk of preeclampsia and gestational hyper-
tension was present in all women with excessive GWG, except those who were underweight
prior to pregnancy [9], while others found a positive association across all BMI categories [28].
In order to explore whether the pre-pregnancy BMI may modify the association between preg-
nancy weight gain and HDP risk, we stratified the asso ciation by maternal pre-pregnancy BMI
categories, and found a significant association between excessive GWG during the whole preg-
nancy and an elevated risk of HDP across all the pre-pregnancy BMI categories. Our results
also suggested that although the risk of HDP increased with excessive GWG, the risk decreased
as pre-pregnancy BMI increased. A similar trend was observed in the stratified results from
previous studies [29, 30]. However, the results for early pregnancy GWG with HDP stratified
by pre-pregnancy BMI showed a different trend in that the association between early preg-
nancy GWG and HDP was only significant among women who were normal weight and over-
weight/obese before pregnancy. The risk of HDP was not significantly increased among
women who were underweight and who had higher GWG during early pregnancy, and was
highest among women who were overweight/obese before pregnancy and who had the highest
level of early GWG. The different trends observed between whole pregnancy GWG and early
pregnancy GWG when stratified by pre-pregnancy BMI might be explained by the different
levels of edema at the middle or late stage of pregnancy across different pre-pregnancy BMI
categories, which needs to be examined by further prospective studies. Excessive weight gain
during early pregnancy, which may result from changes in diet and physical activity levels
including among women with normal pre-pregnancy BMIs, may lead to an increased risk of
HDP through mechanisms involving oxidative stress [7].
Additionally, we evaluated the risk of gestational hypertension and preeclampsia separately,
and also observed a positive association with pre-pregnancy BMI category, whole pregnancy
GWG, BMI gain, and early pregnancy GWG for both outcomes. The association of excessive
GWG during the whole pregnancy and gestational hypertension alone was consistent with a
large scale cohort study conducted in the United States [7]. As gestational hypertension is by
definition not characterized by proteinuria, women with gestational hypertension would be
expected to have less edema; thus, the impact of weight gain should be more likely to be driven
by adiposity rather than edema in the process of disease.
Several strengths and limitations should be noted when interpreting the results of our study.
A clear strength of this study is the large population-based cohort of pregnant women. Also,
the womens anthropometric characteristics during early pregnancy were available, which
allowed us to evaluate the role of both total GWG and early GWG in relation to risk of HDP.
To our knowledge, we are only the second study to examine the association of early GWG with
the risk of HDP, and the first among Asian women. Several limitations of this study should
also be considered. First, though we assessed some potential confounding factors previously
reported to influence HDP, there were several other potential confounders that we were not
able to evaluate, such as smoking status and family history of HDP, because of the absence of
this information in our database. However, we note that the smoking prevalence of women in
China is very low [31] and we excluded women with a history of chronic hypertension or car-
diovascular disease prior to pregnancy from the study. Additionally, our study relies on a self-
reported pre-pregnancy weight, which may be under estimated. Although potential misclassifi-
cation bias may exist, previous studies suggest that the resulting BMI category from self-
reported data rarely alters, and the self-reported weight and height may be considered to be an
acceptable substitute for actual measurements [28, 32].
In conclusion, we conducted a large population-based cohort study in China to evaluate the
association of pre-pregnancy BMI and GWG with the risk of HDP, and found evidence that
pre-pregnancy BMI, total GWG, and early pregnancy GWG were all positively associated with
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 8/10
risk of gestational hypertension and preeclampsia. Our results indicate that maternal over-
weight/obesity, early GWG, and total GWG should be considered in combination in targeting
and reducing the risk of HDP. Weight restrictions before and during pregnancy are both
important in the control of HDP, but weight gain reduction during pregnancy is much more
feasible.
Supporting Information
S1 Table. Associations of pre-pregnancy BMI, gestational BMI gain, and total GWG with
risk of subtypes of HDP (n = 84,656).
(DOCX)
S2 Table. Associations of GWG during early pregnancy (up to 18 weeks) with risk of sub-
types of HDP (n = 63,603).
(DOCX)
Acknowledgments
We are extremely grateful to Wuhan Health Bureau, and all the ho spitals and community
health centers involved in this study.
Author Contributions
Conceived and designed the experiments: BZ TZ. Performe d the experiments: RH SY LQ. Ana-
lyzed the data: CX CY WX. Contributed reagents/materials/analysis tools: Yiming Zhang AZ
SX ZQ. Wrote the paper: CX AZ BB ET YW Yaqi Zhang.
References
1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005, 365(9461):785799.
2. Högberg U. The World Health Report 2005:"Make every mother and child count''including Africans.
Scandinavian journal of public health. 2005, 33(6):409411. PMID: 16332605
3. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia
in healthy nulliparous women: a prospective multicenter study. American journal of obstetrics and gyne-
cology. 1995, 172(2):642648. PMID: 7856699
4. Rosser ML, Katz NT. Preeclampsia: an obstetrician's perspective. Advances in chronic kidney disease.
2013, 20(3):287296. doi: 10.1053/j.ackd.2013.02.005 PMID: 23928395
5. Ehrenthal DB, Jurkovitz C, Hoffman M, Jiang X, Weintraub WS. Prepregnancy body mass index as an
independent risk factor for pregnancy-induced hypertension. Journal of Women's Health. 2011, 20
(1):6772. doi: 10.1089/jwh.2010.1970 PMID: 21194273
6. Sohlberg S, Stephansson O, Cnattingius S, Wikström A-K. Maternal body mass index, height, and risks
of preeclampsia. American journal of hypertension. 2012, 25(1):120125. doi: 10.1038/ajh.2011.175
PMID: 21976280
7. Swank ML, Caughey AB, Farinelli CK, Main EK, Melsop KA, Gilbert WM, et al. The impact of change in
pregnancy body mass index on the development of gestational hypertensive disorders. Journal of peri-
natology: official journal of the California Perinatal Association. 2014, 34(3):181185.
8. Heude B, Thiébaugeorges O, Goua V, Forhan A, Kaminski M, Foliguet B, et al. Pre-pregnancy body
mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension,
and birth outcomes. Maternal and child health journal. 2012, 16(2):355363. doi: 10.1007/s10995-011-
0741-9 PMID: 21258962
9. de la Torre L, Flick AA, Istwan N, Rhea D, Cordova Y, Dieguez C, et al. The effect of new antepartum
weight gain guidelines and prepregnancy body mass index on the development of pregnancy-related
hypertension. American journal of perinatology. 2011, 28(04):285292.
10. Thomson AM, Hytten FE, Billewicz WZ. THE EPIDEMIOLOGY OF OEDEMA DURING PREGNANCY.
BJOG: An International Journal of Obstetrics & Gynaecology. 1967, 74(1):110.
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 9/10
11. Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Gestational weight gain as a risk factor
for hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2013, 209(4):327 e1e17.
12. Reyes LM, García RG, Ruiz SL, Camacho PA, Ospina MB, Aroca G, et al. Risk factors for preeclampsia
in women from Colombia: a case-control study. PloS one. 2012, 7(7):e41622. doi: 10.1371/journal.
pone.0041622 PMID: 22911827
13. Yazdani S, Yosofniyapasha Y, Nasab BH, Mojaveri MH, Bouzari Z. Effect of maternal body mass index
on pregnancy outcome and newborn weight. BMC research notes. 2012, 5(1):34.
14. Bei-Fan Z. Predictive values of body mass index and waist circumference for risk factors of certain
related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist cir-
cumference in Chinese adults. Asia Pacific journal of clinical nutrition. 2002, 11(s8):S685S693.
15. Yaktine AL, Rasmussen KM. Weight Gain During Pregnancy: Reexamining the Guidelines : National
Academies Press. 2009.
16. Brown MA, Lindheimer MD, de Swiet M, Assche AV, Moutquin J-M. The classification and diagnosis of
the hypertensive disorders of pregnancy: statement from the International Society for the Study of
Hypertension in Pregnancy (ISSHP). Hypertension in pregnancy. 2001, 20(1):ixxiv. PMID: 12044323
17. Yu C, Teoh T, Robinson S. Review article: obesity in pregnancy. BJOG: An International Journal of
Obstetrics & Gynaecology. 2006, 113(10):11171125.
18. OBrien TE, Ray JG, Chan W-S. Maternal body mass index and the risk of preeclampsia: a systematic
overview. Epidemiology. 2003, 14(3):368374. PMID: 12859040
19. Morikawa M, Yamada T, Yamada T, Sato S, Cho K, Minakami H. Effects of nulliparity, maternal age,
and pre-pregnancy body mass index on the development of gestational hypertension and preeclamp-
sia. Hypertension Research in Pregnancy. 2013, 1(2):7580.
20. Haugen M, Brantsæter AL, Winkvist A, Lissner L, Alexander J, Oftedal B, et al. Associations of pre-
pregnancy body mass index and gestational weight gain with pregnancy outcome and postpartum
weight retention: a prospective observational cohort study. BMC pregnancy and childbirth. 2014, 14
(1):201.
21. Dekker G, Robillard P-Y. The birth interval hypothesisdoes it really indicate the end of the primipater-
nity hypothesis. Journal of reproductive immunology. 2003, 59(2):245251. PMID: 12896826
22. Wang JX, Knottnerus A-M, Schuit G, Norman RJ, Chan A, Dekker GA. Surgically obtained sperm, and
risk of gestational hypertension and pre-eclampsia. The Lancet. 2002, 359(9307):673674.
23. Sibai B, Ewell M, Levine R, Klebanoff M, Esterlitz J, Catalano P, et al. Risk factors associated with pre-
eclampsia in healthy nulliparous women. American journal of obstetrics and gynecology. 1997, 177
(5):10031010. PMID: 9396883
24. Swank M, Caughey A, Farinelli C, Main E, Melsop K, Gilbert W, et al. The impact of change in preg-
nancy body mass index on the development of gestational hypertensive disorders. Journal of Perinatol-
ogy. 2014, 34:181185. doi: 10.1038/jp.2013.168 PMID: 24384780
25. Lijnen HR. Angiogenesis and obesity. Cardiovascular research. 2008, 78(2):286293. PMID:
18006485
26. Siega-Riz AM, Viswanathan M, Moos M-K, Deierlein A, Mumford S, Knaack J, et al. A systematic
review of outcomes of maternal weight gain according to the Institute of Medicine recommendations:
birthweight, fetal growth, and postpartum weight retention. American journal of obstetrics and gynecol-
ogy. 2009, 201(4):339. e1e14. doi: 10.1016/j.ajog.2009.07.002 PMID: 19788965
27. Tanaka T, Ashihara K, Nakamura M, Kanda T, Fujita D, Yamashita Y, et al. Associations between the
pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in Japanese
women. Journal of Obstetrics and Gynaecology Research. 2014, 40(5):12961303. doi: 10.1111/jog.
12353 PMID: 24750440
28. Johnson J, Clifton RG, Roberts JM, Myatt L, Hauth JC, Spong CY, et al. Pregnancy outcomes with
weight gain above or below the 2009 Institute of Medicine guidelines. Obstetrics and gynecology. 2013,
121(5):969. doi: 10.1097/AOG.0b013e31828aea03 PMID: 23635732
29. Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden.
International Journal of Gynecology & Obstetrics. 2006, 93(3):269274.
30. Liu J, Gallagher AE, Carta CM, Torres ME, Moran R, Wilcox S. Racial differences in gestational weight
gain and pregnancy-related hypertension. Annals of epidemiology. 2014, 24(6):441447. doi: 10.1016/
j.annepidem.2014.02.009 PMID: 24685832
31. Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. New England Journal of Medicine. 2011,
364(25):24692470. doi: 10.1056/NEJMc1102459 PMID: 21696322
32. Huber LRB. Validity of self-reported height and weight in women of reproductive age. Maternal and
child health journal. 2007, 11(2):137144. PMID: 17066316
Pre-Pregnancy BMI, Gestational Weight Gain, and HDP
PLOS ONE | DOI:10.1371/journal.pone.0136291 August 25, 2015 10 / 10
... The risk of preeclampsia in Latin American women increased by over three times in overweight and obese women 32 . Studies have shown an association between maternal overweightness/obesity before pregnancy and an increased risk of HDP among Chinese women and in sub-Saharan Africa 32,34 . A study in Denmark concluded that mothers with HDP and a history of diabetes, compared with offspring of mothers with HDP alone, had a 57% higher risk of infant mortality 6 . ...
... 29,[30][31][32][33][34][35][36][37][38][39], and 40-50. All statistical analyses are performed with SAS Software Version 9.4 (SAS Institute Inc.). ...
Preprint
Full-text available
Hypertensive disorders of pregnancy (HDP) are a group of high blood pressure disorders during pregnancy that are a leading cause of maternal and infant morbidity and mortality. The trend of HDP among the Medicaid population during the coronavirus disease of 2019 (COVID-19) is severely lacking. To determine the trends in the annual prevalence of HDP among Louisiana Medicaid pregnant women before and during the COVID-19 pandemic (2016-2021), a total of 113,776 pregnant women aged 15-50 years was included in this study. For multiparous individuals, only the first pregnancy was used in the analyses. Women with a diagnosis of each type-specific HDP were identified by using the ICD-10 codes. The prevalence of HDP increased from 10.5% in 2016 to 17.7% in 2021. The highest race/ethnicity-specific incidence of HDP was seen in African American women (13.1%), then white women (9.4%), followed by other women (7.9%). HDP remains as a very prevalent and significant global health issue, especially in African American women. Obesity and physical inactivity are major risk factors of HDP, which became amplified during the COVID-19 pandemic and led to a higher prevalence of HDP. Severe HDP substantially increases the risk of mortality in offspring and long-term issues in both the mother and infant. This is very pertinent to the Medicaid population due to the disparities and barriers that diminish the quality of healthcare they receive.
... The differences with IOM are most likely due to environmental, dietary, and ethnic differences and sample size. Yawen Chen studied 6925 twin pregnant women who gave birth in Wuhan from 2011 to 2017 and obtained the recommendations of GWG, which is 18-26 kg for underweight (16)(17)(18)(19)(20)(21).5 kg in our study), 15-25 kg for normal weight(15-21.1 kg in our study), 12-21 kg for overweight(13-20 kg in our study), and 9-20 kg for obese(9-22 kg in our study) 14 . ...
... Insufficient weight gain decreases the incidence of preeclampsia by reducing adipose tissue, thereby reducing inflammation 16,17 . This result is consistent with previous studies 16,[18][19][20] . The rates of GDM were higher for women with lower weekly GWG in all BMI groups, and the incidence of GDM was significantly different in the other three groups except the obese group. ...
Article
Full-text available
There is a lack of data on gestational weight gain (GWG) in twin pregnancies. We divided all the participants into two subgroups: the optimal outcome subgroup and the adverse outcome subgroup. They were also stratified according to prepregnancy body mass index (BMI): underweight (< 18.5 kg/m²), normal weight (18.5–23.9 kg/m²), overweight (24–27.9 kg/m²), and obese (≥ 28 kg/m²). We used 2 steps to confirm the optimal range of GWG. The first step was proposing the optimal range of GWG using a statistical-based method (the interquartile range of GWG in the optimal outcome subgroup). The second step was confirming the proposed optimal range of GWG via compared the incidence of pregnancy complications in groups below or above the optimal GWG and analyzed the relationship between weekly GWG and pregnancy complications to validated the rationality of optimal weekly GWG through logistic regression. The optimal GWG calculated in our study was lower than that recommended by the Institute of Medicine. Except for the obese group, in the other 3 BMI groups, the overall disease incidence within the recommendation was lower than that outside the recommendation. Insufficient weekly GWG increased the risk of gestational diabetes mellitus, premature rupture of membranes, preterm birth and fetal growth restriction. Excessive weekly GWG increased the risk of gestational hypertension and preeclampsia. The association varied with prepregnancy BMI. In conclusion, we provide preliminary Chinese GWG optimal range which derived from twin-pregnant women with optimal outcomes(16–21.5 kg for underweight, 15–21.1 kg for normal weight, 13–20 kg for overweight), except for obesity, due to the limited sample size.
... Adipose tissue is known to be associated with metabolic syndrome, obesity, and dyslipidemia, which can induce inflammatory changes and subsequently lead to increased oxidative stress. This leads to endothelial dysfunction, prothrombotic changes, hypoperfusion of the placenta and preeclampsia [8]. ...
Article
Full-text available
The aim: to investigate and analyze clinical parameters, laboratory biomarkers of lipid metabolism and endothelial dysfunction gene polymorphisms in early-onset and late-onset preeclampsia and to identify potential risk factor(s) for the development of early-onset preeclampsia. Materials and methods: a prospective case-control study included 133 women in the second half of pregnancy, including 46 with early-onset (EOP) and 87 with late-onset preeclampsia (LOP) and 34 conditionally healthy pregnant women with an uncomplicated obstetric history and no risk factors for preeclampsia. Concentrations of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides in blood plasma were determined. Genetic polymorphisms of endothelial dysfunction (192 Q→R PON-1, 677 C→ T MTHFR) were studied using allele-specific polymerase chain reaction. Results: Early-onset preeclampsia is associated with an increased relative risk: preterm delivery by 2.08 times (95 % CI 1.48-2.93), operative delivery by 2.2 times (95 % CI 1.46-3.33), early operative delivery by 2.9 times (95 % CI 1.5-5.5), fetal distress during delivery by 3.78 times (95 % CI 1.2-11.9), a low score on the Apgar scale on the 1st minute, less than 6 points, by 2.59 times (95 % CI 1.84-3.66), on the 5th minute – 5.04 times (95 % CI 1.41-18.11), Grade III prematurity – 13.24 times (95 % CI 3.14-55.78) compared to women with late-onset preeclampsia. The study found that overweight was more often observed in patients with EOP (34.8 %) than in those with normal pregnancy (15.9 %) (p=0.02; OR=2.8; 95 % CI 1.03-7.7), obesity (BMI > 30 kg/m2) was more often recorded in those with LOP (33.33 %) than in the control group (3 (6.8 %)) (p=0.02; OR=6.8; 95 % CI 1.9-23.9). Patients in both groups with preeclampsia showed signs of dyslipidemia, but its significance in the development of early-onset or late-onset preeclampsia has not been separately proven. The study found that the number of carriers of MTHFR 677 TT in the group with EOP prevailed over the indicator of C group where there were no carriers of the pathological homozygote 677TT (p<0.05, OR= 20.73 95 % CI 1.16-371.28), and the T allele in the EOP group occurs 1.78 times more often than in the LOP group (p<0.05, OR=2.22; 95 % CI 1.26-3.88) and 2.43 times more often than in the C group (P<0.05, or= 3.15; 95 % CI 1.54-6.45). Conclusions: Factors of early onset of PE include pre-pregnancy, overweight, first pregnancy, a history of preeclampsia, and carrier of the 677T allele of the MTHFR gene
... Some studies reported that macrosomia has a higher risk of becoming overweight or obesity in the future, while LBW or SGA has a higher risk of developing noninfectious chronic disease according to the theory of Development Origins of Health and Disease. 23 Therefore, it is necessary to improve the infant health through keeping maternal first trimester BMI and GWG in normal range. ...
Article
Full-text available
Introduction: Malnutrition and poor weight gain as well as maternal obesity have significant influences on the pregnancy outcome. This study aims to show the effect of first-trimester body mass index and the corresponding gestational weight gain on the outcome of pregnancy. Method: It was a cross-sectional study conducted from 2017 to 2018. The sample size of the study was 740 respondents, which is calculated based on N=Z²pq/d² formulae, where Z=1.96 for 95% CI, p=11.5, q=100-p and d=2.3(20%) of permissible error of prevalence. Frequency, percentage, mean and standard deviation were calculated for descriptive analysis. Chi-square test was used to find out the association for categorical variables. Odds Ratio and Logistic regression were also calculated for categorical variables. Result: Most of the women (57.3%) had normal Body Mass Index (BMI). Compared to women of adequate Gestational Weight Gain (GWG), the Odds Ratio of Hypertensive Disorder in Pregnancy (HDP), Gestational Diabetes Mellitus (GDM), induction of labor and instrumental/caesarean delivery for women of excessive GWG was 3.88(95%, CI 1.65-9.12,p<0.05), 0.63(95% CI 0.24-1.63), 1.87(95% CI 1.11- 3.15,p<0.05), and 1.93(95% CI 1.14-3.27, p<0.05) respectively. Compared to women of normal BMI, the Odds Ratio of HDP, GDM, induction of labor and instrumental /caesarean delivery for overweight/obese women were 2.32(95% CI 1.15-4.66,p<0.05), 1.94(95% CI 1.10-3.41,p<0.05), 1.15(95% CI 0.75-1.77), 1.48(95% CI 0.96-2.28), respectively. Regarding neonatal outcomes, the OR of macrosomia and APGAR score <7 at 1&5 minute in the overweight/obese-group were 1.61(95% CI 0.56-4.61), 1.24(95% CI 0.21-7.25), and 2.04(95% CI 0.07-55.3), respectively. Conclusion: Both overweight/obesity and excessive GWG are the risk factors of Hypertensive Disorder in Pregnancy, induction of labor, instrumental/cesarean delivery, macrosomia, and APGAR<7 at1&5 minutes.
Article
Full-text available
Objectives The objective was to investigate the associations of maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG) trajectories with adverse pregnancy outcomes (APOs). Design This was a prospective cohort study. Setting This study was conducted in Shanghai Pudong New Area Health Care Hospital for Women and Children, Shanghai, China. Primary and secondary outcome measures A cohort study involving a total of 2174 pregnant women was conducted. Each participant was followed to record weekly weight gain and pregnancy outcomes. The Institute of Medicine classification was used to categorise prepregnancy BMI, and four GWG trajectories were identified using a latent class growth model. Results The adjusted ORs for the risks of large for gestational age (LGA), macrosomia, gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDP) were significantly greater for women with prepregnancy overweight/obesity (OR=1.77, 2.13, 1.95 and 4.24; 95% CI 1.3 to 2.42, 1.32 to 3.46, 1.43 to 2.66 and 2.01 to 8.93, respectively) and lower for those who were underweight than for those with normal weight (excluding HDP) (OR=0.35, 0.27 and 0.59; 95% CI 0.22 to 0.53, 0.11 to 0.66 and 0.36 to 0.89, respectively). The risk of small for gestational age (SGA) and low birth weight (LBW) was significantly increased in the underweight group (OR=3.11, 2.20; 95% CI 1.63 to 5.92, 1.10 to 4.41; respectively) compared with the normal-weight group; however, the risk did not decrease in the overweight/obese group (p=0.942, 0.697, respectively). GWG was divided into four trajectories, accounting for 16.6%, 41.4%, 31.7% and 10.3% of the participants, respectively. After adjustment for confounding factors, the risk of LGA was 1.54 times greater for women in the slow GWG trajectory group than for those in the extremely slow GWG trajectory group (95% CI 1.07 to 2.21); the risk of SGA and LBW was 0.37 times and 0.46 times lower for women in the moderate GWG trajectory group and 0.14 times and 0.15 times lower for women in the rapid GWG trajectory group, respectively; the risk of macrosomia and LGA was 2.65 times and 2.70 times greater for women in the moderate GWG trajectory group and 3.53 times and 4.36 times greater for women in the rapid GWG trajectory group, respectively; and the women in the other three trajectory groups had a lower risk of GDM than did those in the extremely slow GWG trajectory group, but there was not much variation in the ORs. Notably, different GWG trajectories did not affect the risk of HDP. Conclusions As independent risk factors, excessively high and low prepregnancy BMI and GWG can increase the risk of APOs.
Article
Full-text available
Background: Hypertension in pregnancy is one of the three causes of maternal mortality in Indonesia,which proportion increases every year. More than 25% of maternal deaths in Indonesia in 2017 were causedby hypertension in pregnancy (Profil Kesehatan Indonesia, 2018).Purpose: The purpose of this study was to determine the relationship between MAP, ROT, and BMI onhypertension in pregnancy and to find predictor models of hypertension in pregnancy.Method: This research was conducted at Kedungadem Public Health Center, Bojonegoro Regency with across sectional study method. The sampling technique used purposive sampling with subjects consistingof 100 samples (50 normal tension and 50 hypertension). Data analysis used Chi Square, Logistic BinaryRegression and Area Under Curve.Results: The results showed that a history of preeclampsia (OR 10.29; 95% CI 2.21–47.9), MAP (OR 3.38;95% CI 2.36 4.84), ROT (OR 19.94; 95% CI5.47) -72.71), excess BMI (OR4.06; 95% CI 1.58-10.44), BMIof obesity (OR 4.8; 95% CI 1.26-18.24), were significantly associated with hypertension at 27 weeks of age.The main predictors of hypertension at 27 weeks were positive MAP (AUC 0.874; 95% CI 0.832-0.966; p =0.000) and for predictors at 32 weeks, positive ROT at 27 weeks, 28 weeks and 32 weeks (AUC 0.851; 95%CI 0.914-0.993; p = 0.000).Conclusion: The history of preeclampsia, MAP and BMI were able to predict at 27 weeks of gestation andROT was able to predict at 32 weeks of age.
Article
Full-text available
Background In all studies conducted so far, there was no report about the correlation between excessive gestational weight gain (GWG) and the risk of preeclampsia (PE) in multiparas, especially considering that multiparity is a protective factor for both excessive GWG and PE. Thus, the aim of this retrospective cohort study was to determine whether GWG of multiparas is associated with the increased risk of PE. Methods This was a study with 15,541 multiparous women who delivered in a maternity hospital in Shanghai from 2017 to 2021, stratified by early-pregnancy body mass index (BMI) category. Early-pregnancy body weight, height, week-specific and total gestational weight gain as well as records of antenatal care were extracted using electronic medical records, and antenatal weight gain measurements were standardized into gestational age-specific z scores. Results Among these 15,541 multiparous women, 534 (3.44%) developed preeclampsia. The odds of preeclampsia increased by 26% with every 1 z score increase in pregnancy weight gain among normal weight women and by 41% among overweight or obese women. For normal weight women, pregnant women with preeclampsia gained more weight than pregnant women without preeclampsia beginning at 25 weeks of gestation, while accelerated weight gain was more obvious in overweight or obese women after 25 weeks of gestation. Conclusions In conclusion, excessive GWG in normal weight and overweight or obese multiparas was strongly associated with the increased risk of preeclampsia. In parallel, the appropriate management and control of weight gain, especially in the second and third trimesters, may lower the risk of developing preeclampsia. Graphical Abstract
Article
Full-text available
Background Increasing evidence suggests an association between maternal pre-pregnancy body mass index (pre-BMI) and adverse pregnancy outcomes. However, the effects of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on these relationships require further investigation. This study aimed to investigate whether the relationship between pre-BMI and the risk of adverse pregnancy outcomes was influenced by MTHFR gene polymorphisms. Methods A total of 5614 mother-fetus pairs were included in the study. The odds ratios (OR) of adverse pregnancy complications, including gestational diabetes mellitus (GDM), gestational hypertension (GHT), cesarean delivery (CS), and premature rupture of membranes (PROM), were estimated using adjusted logistic regression models and subgroup analysis. Results Pregnant women with higher pre-BMI values were positively related to the risk of GDM, GHT, and CS. In the subgroup analysis, underweight BMI was associated with a decreased risk of CS and GDM in pregnant women with the MTHFR A1298C AA or C677T CC genotype, while overweight/obese BMI was associated with an increased risk of GDM and CS in different MTHFR variants. Moreover, pregnant women with MTHFR A1298C AC + CC or C667T CC were found to have an increased risk of GHT in the MTHFR A1298C AA or C667T CT + TT genotype. A remarkable association was observed between the obesity group with MTHFR A1298C AC + CC (OR = 6.49, CI: 2.67–15.79) and the overweight group with the C667T CC genotype (OR = 4.72, CI: 2.13–10.45). Conclusions MTHFR gene polymorphisms exert a modifying effect on the association between maternal pre-BMI and the risk of GHT, CS, and GDM. Pregnant women with a high pre-BMI with specific MTHFR genotypes should be considered for GHT development.
Article
Full-text available
Importance: Although certain air pollutants have been associated with adverse obstetric outcomes, evidence regarding the association of ozone (O3) exposure with the risk of hypertensive disorders in pregnancy (HDP) is limited and inconsistent. Objectives: To evaluate the association between gestational O3 exposure and HDP (ie, gestational hypertension and preeclampsia) risk, and to explore the window of susceptibility for O3 exposure during pregnancy. Design, setting, and participants: This cohort study recruited pregnant patients from the Obstetrics and Gynecology Hospital of Fudan University in Shanghai, China, from March 2017 to December 2018. Participants were older than 18 years, had no infectious diseases or chronic noncommunicable diseases before pregnancy, were Shanghai residents with intent to participate in the study, and had plans to give birth in Shanghai. Gestational hypertension and preeclampsia were diagnosed according to the diagnostic criteria of the Chinese Society of Obstetrics and Gynecology during the study period. Data on residential addresses, demographic characteristics, and household living environments were collected from participants through a questionnaire survey. Data were analyzed from December 10, 2021, to May 10, 2022. Exposures: A high temporospatial resolution model was applied to predict individual levels of daily O3 exposure during pregnancy. Main outcomes and measures: The outcomes were gestational hypertension and preeclampsia, and data on these diagnoses were extracted from the hospital's information system. A logistic regression model was used to estimate the associations between O3 exposure and risk of gestational hypertension or preeclampsia. Exposure-response associations were confirmed by restricted cubic spline functions. Distributed lag models were used to identify the O3 exposure window of susceptibility. Results: Among the 7841 participants (all females; mean [SD] age, 30.4 [3.8] years), 255 (3.2%) had gestational hypertension and 406 (5.2%) had preeclampsia. Pregnant individuals with HDP had considerably higher prepregnancy body mass indexes and lower educational levels. The mean (SD) O3 exposure levels were 97.66 (25.71) μg/m3 in the first trimester and 106.13 (22.13) μg/m3 in the second trimester. Each 10-μg/m3 increment of O3 exposure during the first trimester was associated with higher gestational hypertension risk (relative risk, 1.28; 95% CI, 1.04-1.57). However, gestational O3 exposure was not associated with the risk of preeclampsia. The restricted cubic spline function analysis revealed an exposure-response association between O3 exposure and risk of gestational hypertension. Conclusions and relevance: Results of this study showed an association between increased gestational hypertension risk and O3 exposure during the first trimester. Furthermore, gestational weeks 1 to 9 were identified as the window of susceptibility for O3 exposure and elevated gestational hypertension risk. Sustainable O3 control is needed to reduce the disease burden of gestational hypertension.
Article
Full-text available
Nutrition during pregnancy is one of the most important factors that determine the health of a mother and the proper development of her fetus. The main objective of this study was to analyze the association between adherence to a Mediterranean dietary (MedDiet) pattern and cardiovascular (CV) risk factors in pregnant women. Accordingly, we carried out an observational, population-based study using data from pregnant women present in a hospital during the entire course of their pregnancy. Adherence to the MedDiet was assessed using the MedDiet score questionnaire. Our study identified that 87.25% (95%CI: 83.48–90.27) of the women had a cardiovascular risk in relation to their dietary intake. Women with diet-related CV risk were more likely to smoke (p = 0.004), weighed more at the beginning of pregnancy, engaged in little physical activity, and had lower adherence to the MedDiet pattern than women without a diet-related CV risk. Dietary analysis showed low consumption of cereals, vegetables, and fish, which failed to satisfy the recommended portions in Spain. Adequate adherence to the MedDiet was found for 54.2% of women who were considered to be without CV risk and 45.8% of women with CV risk. Our data suggest that the MedDiet could be improved in relation to the consumption of cereals, vegetables, and fish during pregnancy in order to reduce CV risk.
Article
Full-text available
Background Excessive gestational weight gain (GWG) is associated with pregnancy complications, and Norwegian Health Authorities have adopted the GWG recommendations of the US Institute of Medicine and National Research Council (IOM). The aim of this study was to evaluate if a GWG outside the IOM recommendation in a Norwegian population is associated with increased risk of pregnancy complications like hypertension, low and high birth weight, preeclampsia, emergency caesarean delivery, and maternal post-partum weight retention (PPWR) at 6 and 18 months. Methods This study was performed in 56 101 pregnant women included in the prospective national Norwegian Mother and Child Cohort Study (MoBa) in the years 1999 to 2008. Women who delivered a singleton live born child during gestational week 37 to 42 were included. Maternal prepregnant and postpartum weight was collected from questionnaires at 17th week of gestation and 6 and 18 months postpartum. Results A weight gain less than the IOM recommendations (GWG < IOM rec.) increased the risk for giving birth to a low weight baby among normal weight nulliparous women. A weight gain higher than the IOM recommendations (GWG > IOM rec.) significantly increased the risk of pregnancy hypertension, a high birth weight baby, preeclampsia and emergency cesarean delivery in both nulliparous and parous normal weight women. Similar results were found for overweight women except for no increased risk for gestational hypertension in parous women with GWG > IOM rec. Seventy-four percent of the overweight nulliparous women and 66% of the obese women had a GWG > IOM rec. A GWG > IOM rec. resulted in increased risk of PPWR > 2 kg in all weight classes, but most women attained their prepregnant weight class by 18 months post-partum. Conclusions For prepregnant normal weight and overweight women a GWG > IOM rec. increased the risk for unfavorable birth outcomes in both nulliparous and parous women. A GWG > IOM rec. increased the risk of a PPWR > 2 kg at 18 months in all weight classes. This large study supports the Norwegian Health authorities’ recommendations for normal weight and overweight women to comply with the IOM rec.
Article
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of angiogenic growth factors and increased placental debris in the maternal circulation resulting in a (mainly hypertensive) maternal inflammatory response. The final phenotype, maternal pre-eclamptic syndrome, is further modulated by pre-existing maternal cardiovascular or metabolic fitness. Currently, women at risk are identified on the basis of epidemiological and clinical risk factors, but the diagnostic criteria of pre-eclampsia remain unclear, with no known biomarkers. Treatment is still prenatal care, timely diagnosis, proper management, and timely delivery. Many interventions to lengthen pregnancy (eg, treatment for mild hypertension, plasma-volume expansion, and corticosteroid use) have a poor evidence base. We review findings on the diagnosis, risk factors, and pathogenesis of pre-eclampsia and the present status of its prediction, prevention, and management.
Article
Aims: We aimed to determine the effects of nulliparity, maternal age, and pre-pregnancy body mass index (BMI, kg/m²) on the development of pregnancy induced hypertension (PIH) in Japanese women, including gestational hypertension (GH) and preeclampsia (PE). Methods: Data on 138,530 women with singleton pregnancies who were registered with the Japan Society of Obstetrics and Gynecology and gave birth at ≥22 weeks of gestation during the three years from 2007 and 2009 were analyzed. Results: PIH was diagnosed in 6,578 (4.7%) women, including 3,326 (2.4%) with GH and 3,252 (2.3%) with PE. PIH was more frequent in nulliparous than multiparous women (relative risk [95% confidence interval], 1.30 [1.24 to 1.37]) and increased linearly with advancing maternal age after 35 years and also with increasing pre-pregnancy BMI. PIH also varied greatly among 24 groups stratified according to 4 maternal age categories and 6 pre-pregnancy BMI categories, with the lowest frequency (2.7%) among lean (BMI<18.5) women 20–34 years of age and the highest frequency (21.7%) among obese (BMI≥30) women ≥40 years of age. Conclusions: Our findings provide useful information for counseling Japanese women about the risk of PIH at the beginning of pregnancy.
Conference Paper
Since the 1990 IOM guidelines for gestational weight gain (GWG) were released, the demographic profile of American women of childbearing age has become more diverse and an increasing proportion of them are overweight or obese. The 1990 guidelines were designed to minimize infant mortality, but their consequences for women were not evaluated. The IOM/NRC has just released a report that includes guidelines for GWG that are based on a consideration of the health consequences for both infants and their mothers. The conceptual framework used to develop new guidelines was based on current public health models. For the first time, the guidelines are based on WHO/NHLBI categories for body mass index and include a GWG range for obese women. The report calls for improvements in surveillance of GWG and postpartum weight retention and adoption of the revised birth certificate by all states to support this surveillance. In addition, the report recommends that professional societies endorse or adopt these guidelines, that they be publicized to women and that women follow them. The report also calls on women to begin pregnancy at a health weight. To help women achieve this goal as well as a GWG within the guidelines, the report calls for additional preconceptional care and also for prenatal care providers to offer women counseling, such as guidance on dietary intake and physical activity, that is tailored to their life circumstances. Full implementation of the report's recommendations would require a radical change in the care provided to American women of childbearing age.
Article
Objective: To evaluate pregnancy outcomes according to 2009 Institute of Medicine (IOM) gestational weight gain guidelines. Methods: This study is a secondary analysis of a preeclampsia prevention trial among nulliparas carrying singletons. Odds ratios and 95% confidence intervals (adjusted for maternal age, race, smoking, and treatment group) were calculated based on total weight gain below or above the IOM guidelines stratified by prepregnancy body mass index (BMI). The referent group was weight gain within the guidelines. Results: Of 8,293 pregnancies, 9.5% had weight gain below, 17.5% within, and 73% above IOM guidelines. With excess weight gain, all BMI categories had an increased risk of hypertensive disorders; normal weight and overweight women also had increased risk of cesarean delivery and neonatal birth weight at or above the 90 centile but a decreased risk of weight below the 10 centile. There were no consistent associations with insufficient weight gain and adverse outcomes. Conclusion: Excess weight gain was prevalent and associated with an increased risk of hypertensive disorders, cesarean delivery, and large-for-gestational-age neonates.
Article
AimTo examine the associations between the pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) with pregnancy outcomes in Japanese women.Methods The medical records of 1883 Japanese women who delivered singleton infants from January 2010 to January 2013 at Osaka-Minami Medical Center were retrospectively reviewed. We use the BMI classification which the World Health Organization defined for Asian populations and the GWG classified based on the current 2009 Institute of Medicine (IOM) recommendations. The odds ratio (OR) of each of the groups for the different pregnancy outcomes were compared to the recommended group using a logistic regression analysis adjusted by age, gestational weeks, parity, weight gain, mode of delivery, pregnancy induced hypertension (PIH) and gestational diabetes mellitus.ResultsWomen who were obese (BMI, ≥25 kg/m2) and overweight (BMI, 23–24.9 kg/m2) had a higher rate of developing PIH (adjusted OR, 6.68 and 3.21 [95% confidence interval [CI], 3.31–13.3 and 1.29–7.24]). In contrast, GWG exhibited a correlation with the weight of the infant. The inadequate GWG group had a higher rate of small-for-gestational age (SGA) infants (adjusted OR, 1.72 [95% CI, 1.22–2.46]). The rate of emergency cesarean section was not significantly different between the groups.ConclusionA pre-pregnancy BMI less than 23 kg/m2 is desirable to prevent Japanese women from developing PIH. GWG within the IOM recommendations also reduced the risk of PIH and SGA.
Article
Purpose To examine racial differences in gestational weight gain (GWG) and pregnancy-related hypertension. Methods Logistic regression models tested racial differences in adequacy of GWG and pregnancy-induced hypertension in all singleton live births from the South Carolina 2004-2006 birth certificates. Results Compared to white women, black and Hispanic women had 16%-46% lower odds of gaining weight above the recommendations. However, the odds of inadequate GWG was ∼50% higher in black and Hispanic women with a pregnancy body mass index (BMI) <25kg/m2. Furthermore, compared to women with adequate GWG, women with excessive GWG had higher odds of pregnancy-related hypertension (underweight: 2.35, 95% CI(1.66, 3.32); normal: 2.05, 95% CI(1.84, 2.27); overweight: 1.93, 95% CI(1.64, 2.27); obese: 1.46, 95% CI(1.30, 1.63)). Among women with a BMI <25 kg/m2, black women had higher odds of pregnancy-related hypertension than white women (underweight: 1.64, 95% CI(1.14, 2.36); normal weight: 1.28, 95% CI(1.15, 1.42)), while among women with a BMI ≥25 kg/m2, Hispanic women had 40% lower odds. Conclusion Programs are needed to curb excessive GWG in all racial groups and to help some sub-groups ensure adequate GWG. Maternal obesity and GWG are two factors that should be used in combination to reduce racial differences in pregnancy-related hypertension.
Article
Objective: To examine the impact of change in body mass index (BMI) during pregnancy on the incidence of gestational hypertension/preeclampsia. Study design: This is a retrospective cohort study using linked California birth certificate and discharge diagnosis data from the year 2007. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were calculated for the outcome of gestational hypertension/preeclampsia, as a function of a categorical change in pregnancy BMI: BMI loss (<-0.5), no change (-0.5 to 0.5), minimal (0.6 to 5), moderate (5.1 to 10) and excessive (>10). The impact of change in pregnancy BMI was evaluated for the entire cohort and then as a function of prepregnancy BMI category. Women with no change in pregnancy BMI served as the reference group. Result: The study population consisted of 436 414 women with singleton gestations. Overall, women with excessive BMI change had a nearly twofold increased odds of gestational hypertension/preeclampsia (aOR=1.94; 95% CI=1.72 to 2.20). By prepregnancy BMI class, overweight and obese women who had a moderate change in pregnancy BMI also had increased odds of developing gestational hypertension/preeclampsia with aOR ranging from 1.73 to 1.97. Conclusion: Regardless of prepregnancy BMI category, women with excessive BMI change have a higher chance of developing gestational hypertension/preeclampsia. Overweight and obese women with moderate BMI change may also be at increased risk.